Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study

BACKGROUND: This post-hoc analysis was conducted to evaluate the effect of erenumab on monthly migraine days, monthly migraine attacks, and attack duration in patients with episodic migraine to investigate whether erenumab actually prevents the occurrence of migraine attacks and/or shortens them. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Diener, Hans-Christoph, Ashina, Messoud, Ritter, Shannon, Paiva Da Silva Lima, Gabriel, Rasmussen, Soeren, Zielman, Ronald, Tfelt-Hansen, Peer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504413/
https://www.ncbi.nlm.nih.gov/pubmed/33939497
http://dx.doi.org/10.1177/03331024211010308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504413/
https://www.ncbi.nlm.nih.gov/pubmed/33939497
http://dx.doi.org/10.1177/03331024211010308

Ejemplares similares